By Aveluro Research Team · Editorial policy
VMD (VMD) is a company in Vietnam's Health Care sector, listed on HOSE. The stock last traded at 14,000 VND, little changed on the session, giving a market capitalization of 223.9 billion VND.
On valuation, VMD trades at a price-to-earnings ratio of 8.2 and a price-to-book of 0.5. That is a discount to the Health Care sector average P/E of 22.2. Return on equity of 6.5% points to modest profitability relative to the company's equity base, below the sector average of 10.4%. Trailing earnings per share stand at 1,778 VND.
Aveluro tracks 6 news items mentioning VMD, where recent coverage skews negative (100% of articles). The most recent catalyst was a leadership change event — "Vimedimex Pharma (VMD) Leaders Resign Ahead of 2026 AGM; HoSE Flags Late Filing". Aveluro's composite model rates VMD 6.2/10 (Hold), blending news sentiment, price momentum, and fundamentals.
Average daily volume over the past 10 sessions is roughly 1,700 shares; liquidity is relatively thin, so single headlines can move the price sharply. Comparable names in the Health Care sector include AGP, AMV and APC.
What matters now
Vimedimex Pharma (VMD) Leaders Resign Ahead of 2026 AGM; HoSE Flags Late Filing
Caveat: Not investment advice. · How Aveluro computed this: Aveluro combines extracted event facts, source credibility, ticker context, and market data. Scores are deterministic research signals, not recommendations.
Low liquidity — thin average daily volume may result in wider spreads and price impact on larger orders.